Skip To Main Content
RPh Margo Walters on Muck Rack

RPh Margo Walters

As seen in: U.S. Pharmacist
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with RPh Margo

Contact RPh Margo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Resmetirom for Metabolic Dysfunction–Associated Steatohepatitis

|
By Jackson J. Dubas, RPh Margo Walters, RPh Shana Castillo
| U.S. Pharmacist Verified
GASTROENTEROLOGY   •   Published April 16, 2026 In 2024, resmetirom became the first FDA-approved treatment for adults who have noncirrhotic metabolic dysfunction–associated steatohepatitis with moderate-to-advanced fibrosis. Jackson Dubas, PharmD, RPhMargo Walters, PharmD, RPhShana Castillo, PharmD, MBA, RPhLaura Klug, PharmD, RPhEric Hoie, PharmD, RPh Author accreditations GASTROENTEROLOGYDRUG APPROVALSSpecialty PharmacyHepatitisNASH US Pharm. 2026;51:37-40.
Open in Who Shared Issue with article?
See all 1 articles